Immunotherapy of CMV Infections
Although cytomegalovirus (CMV) infection is common, the majority of infections cause little or no symptoms. Serious disease occurs virtually exclusively in fetuses or neonates and immunosuppressed individuals including those on corticosteroids, transplant recipients, and those with the acquired immunodeficiency syndrome (AIDS). Retinitis, gastrointestinal disease, and interstitial pneumonitis are among the more common manifestations of CMV disease, but infections at other sites also occur.
KeywordsAdoptive Transfer Graft Versus Host Disease Fred Hutchinson Cancer Research Antiidiotype Antibody Graft Versus Host
Unable to display preview. Download preview PDF.
- 4.Bratanow NC, Ash RC, Turner PA, et al. “Successful Treatment of Serious Cytomegalovirus Disease with 9 (1,3-dihydroxy-2-propoxymethyl) Guanine in Bone Marrow Transplant Patients. Blood. 1986;68 Suppl. 1: 280aGoogle Scholar
- 9.Emanual DJ. “Uses of Immunotherapy for Control of Human Cytomegalovirus-Associated Dicrases.” Transplantation Proceedings. 1991;23,Suppl 3: 144–6.Google Scholar
- 12.Aulitzky WE, Schulz TF, Tilg H, et al. “Human Monoclonal Antibodies Neutralizing Cytomegalovirus (CMV) for Prophylaxis of CMV Disease: Report of a Phase I Trial in Bone Marrow Transplant Recipients.” Journal of Infectious Diseases. 1991;163:1344–7_Google Scholar
- 15.Petersen E, Kaplan C, Fish D, et al. “Human Monoclonal Antibody to Cytomegalvirus (TI-23): Pharmacokinetics and Toxicity Study in HIV Seropositive Patients.” Sixth International Conference on AIDS. June 20, 1990.Google Scholar
- 16.Pollard RB, Nokta MA, Pappas P, et al. “A Phase I/IIA Study of a Human Monoclonal Anti-Cytomegalovirus Antibody in Patients with AIDS.” Antiviral Research, 1992;16, Suppl 1: 111.Google Scholar
- 17.Tolpin M, Pollard R, Tierney M, et al. “Combination Therapy of Cytomegalovirus (CMV) Retinitis with a Human Monocloncal Anti-CMV Antibody (SDZ MSL 109) and Either Ganciclovir (DHPG) or Foscarnet (PFA).” IXth International Conference on AIDS. June 6–11, 1993.Google Scholar
- 19.Greenberg PD, Renccer P, Goodrich JM, et al. “Development of a Treatment Regimen for Human Cytomegalovirus (CMV) Infection in Bone Marrow Transplantation Receipients by Adoptive Transfer of Donor-Derived CMV-Specific T Cell Clones Expanded In Vitro Annals New York Academy of Sciences. 1991; 636: 184–95.CrossRefGoogle Scholar